The tumors before immunotherapy of the responding patients (patients 1 and 2) showed no or only low intratumoral infiltration of CD8+ cells with low to moderate accumulation at the tumor margins, while NRAS mutant tumors emerging under therapy showed moderate intratumoral infiltration and moderate to high accumulation of CD8+ cells at the tumor margins. This evidence concerns the gene CD8A and neoplasm.